Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin 5% versus Ringer lactate for surgical hemorrhage replacement and postoperative renal/coagulation outcomes
IRCT20191009045037N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Albumin 5% group with Ringer lactate group (2 arms). Primary endpoints: Changes in coagulation tests, Changes in renal tests and 1 more. Started Oct 2017; status: completed.
02
Drugs
albumin (human)lactated ringer's solution
Beyond the preview
Go deeper on IRCT20191009045037N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191009045037N1.